MoneyWorks4Me

Gland Pharma informs about press release

03 Dec 2024 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Latanoprost Ophthalmic Solution, 0.005% (2.5 mL Fill).

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1756.60
Dr. Reddys Labs. 1224.90
Cipla 1304.50
Lupin 1938.10
Zydus Lifesciences 1118.50
View more..